SP-0589: Role of systemic therapy in the treatment of brain metastases von Dziadziuszko, R

Volltext

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study von Mok, T., Camidge, D.R., Gadgeel, S.M., Rosell, R., Dziadziuszko, R., Kim, D.-W., Pérol, M., Ou, S.-H.I., Ahn, J.S., Shaw, A.T., Bordogna, W., Smoljanović, V., Hilton, M., Ruf, T., Noé, J., Peters, S.

Volltext

SP-0240: Targeted agents, systemic therapy and radiotherapy of non-small cell lung cancer ñ clinical evidence von Dziadziuszko, R

Volltext

Oligo- and hypofractionated stereotactic radiotherapy of lung cancer von Dziadziuszko, R

Volltext

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study von Novello, S., Mazières, J., Oh, I.-J., de Castro, J., Migliorino, M.R., Helland, Å., Dziadziuszko, R., Griesinger, F., Kotb, A., Zeaiter, A., Cardona, A., Balas, B., Johannsdottir, H.K., Das-Gupta, A., Wolf, J.

Volltext

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer von Passaro, A., Leighl, N., Blackhall, F., Popat, S., Kerr, K., Ahn, M.J., Arcila, M.E., Arrieta, O., Planchard, D., de Marinis, F., Dingemans, A.M., Dziadziuszko, R., Faivre-Finn, C., Feldman, J., Felip, E., Curigliano, G., Herbst, R., Jänne, P.A., John, T., Mitsudomi, T., Mok, T., Normanno, N., Paz-Ares, L., Ramalingam, S., Sequist, L., Vansteenkiste, J., Wistuba, I.I., Wolf, J., Wu, Y.L., Yang, S.R., Yang, J.C.H., Yatabe, Y., Pentheroudakis, G., Peters, S.

Volltext

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clini... von Remon, J., Besse, B., Aix, S. Ponce, Callejo, A., Al-Rabi, K., Bernabe, R., Greillier, L., Majem, M., Reguart, N., Monnet, I., Cousin, S., Garrido, P., Robinet, G., Garcia Campelo, R., Madroszyk, A., Mazières, J., Curcio, H., Wasąg, B., Pretzenbacher, Y., Fournier, B., Dingemans, A.-M.C., Dziadziuszko, R.

Volltext

Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung c... von Baumann, M, Herrmann, T, Koch, R, Matthiessen, W, Appold, S, Wahlers, B, Kepka, L, Marschke, G, Feltl, D, Fietkau, R, Budach, V, Dunst, J, Dziadziuszko, R, Krause, M, Zips, D

Volltext

SP-0568 Overview of systemic treatments in metastasised NSCLC von Dziadziuszko, R.

Volltext

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective von Adebahr, S, Collette, S, Shash, E, Lambrecht, M, Le Pechoux, C, Faivre-Finn, C, De Ruysscher, D, Peulen, H, Belderbos, J, Dziadziuszko, R, Fink, C, Guckenberger, M, Hurkmans, C, Nestle, U

Volltext

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform von Morfouace, M., Novello, S., Stevovic, A., Dooms, C., Janžič, U., Berghmans, T., Dziadziuszko, R., Gorlia, T., Felip, E., Paz-Ares, L., Mazieres, J., O’Brien, M., Bironzo, P., Vansteenkiste, J., Lacroix, L., Dingemans, A. C., Golfinopoulos, V., Besse, B.

Volltext

Epidermal growth factor receptor (EGFR) inhibitors and derived treatments von Dziadziuszko, R, Jassem, J

Volltext

Lung cancer research and treatment: global perspectives and strategic calls to action von Meyer, M.-L., Peters, S., Mok, T.S., Lam, S., Yang, P.-C., Aggarwal, C., Brahmer, J., Dziadziuszko, R., Felip, E., Ferris, A., Forde, P.M., Gray, J., Gros, L., Halmos, B., Herbst, R., Jänne, P.A., Johnson, B.E., Kelly, K., Leighl, N.B., Liu, S., Lowy, I., Marron, T.U., Paz-Ares, L., Rizvi, N., Rudin, C.M., Shum, E., Stahel, R., Trunova, N., Bunn, P.A., Hirsch, F.R.

Volltext

20IN THE POINT OF VIEW OF THE RADIATION ONCOLOGIST von Dziadziuszko, R

Volltext

Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations von Błaszkowska, M., Specht-Szwoch, Z., Dziadziuszko, R.

Volltext

SP-0018 Optimal management of patients with unresectable stage III NSCLC: areas of controversy and ongoing research von Dziadziuszko, R.

Volltext

IBS31.02 Novel Drug Access: Dream Versus Reality von Dziadziuszko, R.

Volltext

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts von Putora, P.M., Fischer, G.F., Früh, M., Califano, R., Faivre-Finn, C., Van Houtte, P., McDonald, F., Nestle, U., Dziadziuszko, R., Le Pechoux, C., Ramella, S., Belderbos, J., Slotman, B.J., Troost, E.G.C., Peeters, S., Widder, J., Pöttgen, C., Reck, M., Blackhall, F., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Paz Ares, L., de Marinis, F., Westeel, V., De Ruysscher, D.

Volltext

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib von Hirsch, FR, Varella-Garcia, M, Cappuzzo, F, McCoy, J, Bemis, L, Xavier, AC, Dziadziuszko, R, Gumerlock, P, Chansky, K, West, H, Gazdar, AF, Crino, L, Gandara, DR, Franklin, WA, Bunn, PA

Volltext

Clinical experience and management of adverse events in patients with advanced ALK-positive non-small-cell lung cancer receiving alectinib von Dziadziuszko, R., Peters, S., Ruf, T., Cardona, A., Guerini, E., Kurtsikidze, N., Smoljanovic, V., Planchard, D.

Volltext